Source: International Congress 2016 – Immune responses in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lara Ravanetti (Amsterdam, Netherlands), Lara Ravanetti, Annemiek Dijkhuis, Yanaika S. Sabogal Pineros, Renè Lutter. Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma. Eur Respir J 2016; 48: Suppl. 60, 3632

Member's Comments

No comment yet.

Related content which might interest you: RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Increased levels of apoptotic and necrotic markers during asthma exacerbation Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Expression of type I and III interferons in experimental allergic asthma and after dsRNA-induced exacerbation Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Characterisation of a steroid-insensitive severe asthma model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Adjuvant-free mouse model of allergic asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Characterization of an endogenous Th17-cell generation during sensitization in the murine lung Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Crucial timing of a viral component exposure to exacerbate allergen-induced asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection Source: International Congress 2016 – Immune responses in the lung Year: 2016 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 A new model for analysis of chronic bronchial interleukin-8 expression Source: International Congress 2016 – Airway response to infection Year: 2016 Standardization of a murine model of asthma due to soybean inhalation Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 The role of lL-17 in the OVA-LPS driven model of lung inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Immunomodulatory role of IL-37 in asthma pathogenesis Source: International Congress 2016 – Immune responses in the lung Year: 2016 Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014